May 6, 2026 · Form 4 insider transaction
VARKI PAUL bought 62,500 shares of Avalo Therapeutics, Inc. at $13.43 per share, a transaction worth $839.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2025.